Standard chemotherapeutics, such as cisplatin, are ineffective on metastatic melanoma and we, and others, have shown that levels of a number of NER proteins in melanoma cells are elevated in response to cisplatin: ERCC1 and XPF [17], XPC and DDB2 [29], XPA (this publication). The gene discussed is ERCC4; the disease is melanoma.